NTEC - Intec Pharma Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
0
0
0
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
0
Operating Expenses
Research Development
35,163
35,402
24,295
10,749
4,791
Selling General and Administrative
8,617
7,926
5,117
3,072
2,754
Total Operating Expenses
43,780
43,328
29,439
13,846
7,564
Operating Income or Loss
-43,780
-43,328
-29,439
-13,846
-7,564
Interest Expense
-
23
17
16
15
Total Other Income/Expenses Net
-
-941
106
324
392
Income Before Tax
-53,489
-43,440
-29,064
-13,362
-7,143
Income Tax Expense
157
103
29
-
-
Income from Continuing Operations
-53,646
-43,543
-29,093
-13,362
-7,143
Net Income
-53,646
-43,543
-29,093
-13,362
-7,143
Net Income available to common shareholders
-53,646
-43,543
-29,093
-13,362
-7,143
Reported EPS
Basic
-
-1.40
-1.65
-1.17
-0.92
Diluted
-
-1.40
-1.65
-1.17
-0.92
Weighted average shares outstanding
Basic
-
31,193
17,660
11,448
7,791
Diluted
-
31,193
17,660
11,448
7,791
EBITDA
-
-42,558
-28,218
-12,645
-6,385